AU4373297A - Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof - Google Patents

Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof

Info

Publication number
AU4373297A
AU4373297A AU43732/97A AU4373297A AU4373297A AU 4373297 A AU4373297 A AU 4373297A AU 43732/97 A AU43732/97 A AU 43732/97A AU 4373297 A AU4373297 A AU 4373297A AU 4373297 A AU4373297 A AU 4373297A
Authority
AU
Australia
Prior art keywords
nanoerythrosomes
making same
polyethyleneglycol
conjugated
polyethyleneglycol conjugated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43732/97A
Inventor
Francois Bellemare
Rene Gaudreault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagnocure Inc
Original Assignee
Diagnocure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnocure Inc filed Critical Diagnocure Inc
Publication of AU4373297A publication Critical patent/AU4373297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
AU43732/97A 1996-09-19 1997-09-19 Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof Abandoned AU4373297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2636396P 1996-09-19 1996-09-19
US60026363 1996-09-19
PCT/CA1997/000698 WO1998011919A2 (en) 1996-09-19 1997-09-19 Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof

Publications (1)

Publication Number Publication Date
AU4373297A true AU4373297A (en) 1998-04-14

Family

ID=21831380

Family Applications (2)

Application Number Title Priority Date Filing Date
AU43733/97A Abandoned AU4373397A (en) 1996-09-19 1997-09-19 Method of capture of a bioactive agent by a nanoerythrosome preparation
AU43732/97A Abandoned AU4373297A (en) 1996-09-19 1997-09-19 Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU43733/97A Abandoned AU4373397A (en) 1996-09-19 1997-09-19 Method of capture of a bioactive agent by a nanoerythrosome preparation

Country Status (5)

Country Link
EP (1) EP0929317A2 (en)
JP (1) JP2001501190A (en)
AU (2) AU4373397A (en)
CA (1) CA2266388A1 (en)
WO (2) WO1998011920A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10000838B4 (en) 2000-01-12 2005-03-17 Schott Ag Alkali-free aluminoborosilicate glass and its uses
EP1403639A1 (en) 2002-09-30 2004-03-31 G2M Cancer Drugs AG Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases
US7432331B2 (en) 2002-12-31 2008-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
KR101025143B1 (en) 2002-12-31 2011-04-01 넥타르 테라퓨틱스 Hydrolytically stable maleimide-terminated polymers
EP2015071A1 (en) * 2007-07-13 2009-01-14 FUJIFILM Corporation Carrier, process for producing same, bioreactor, and chip for surface plasmon resonance analysis
US20130202625A1 (en) * 2010-01-21 2013-08-08 The Regents Of The University Of Californa Use of human erythrocytes for prevention and treatment of cancer dissemination and growth

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2150617C (en) * 1995-02-07 2001-10-30 Universite Laval Nanoerythrosome as bioactive agent carrier

Also Published As

Publication number Publication date
AU4373397A (en) 1998-04-14
WO1998011919A2 (en) 1998-03-26
CA2266388A1 (en) 1998-03-26
WO1998011919A3 (en) 1998-06-04
EP0929317A2 (en) 1999-07-21
JP2001501190A (en) 2001-01-30
WO1998011920A2 (en) 1998-03-26
WO1998011920A3 (en) 1998-05-22

Similar Documents

Publication Publication Date Title
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
AU5186498A (en) Nanotubes, use and manufacture of same
AU4059897A (en) Kinesiologic mouthpiece and method
AU2440997A (en) Calixpyrroles, calixpyridinopyrroles and calixpyridines
AU5752398A (en) Novel ketobenzamides and their use
AU5081298A (en) Surgical method and composition therefor
AU6864698A (en) Surgical template and surgical method employing same
AU4772597A (en) Novel phospholipase, production and use thereof
AU6337098A (en) Disposable wireless telephone and method
AU3767097A (en) Shampoo compositions and method
AU3091897A (en) Surf-or-sail-board and method of producing the same
AU1532297A (en) Starch-emulsifier composition and methods of making
ZA971964B (en) Azolobenzazepine derivatives and compositions and method of use thereof.
AUPO163696A0 (en) Lighting devices, methods of constructing lighting devices and methods of operating lighting devices
AU3492997A (en) Soi-transistor circuitry employing soi-transistors and method of manufacture thereof
AU6270799A (en) Firestarter and method of making same
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU3118297A (en) Sok-1 and methods of use
AU5689498A (en) Monoamines and a method of making the same
AU4373297A (en) Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof
AU3200197A (en) New composition and methods
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
AU8578598A (en) Anti-inflammatory factor, method of isolation, and use
AU5878398A (en) Evaporator making method, such evaporator and use thereof
AU5557698A (en) Novel calpaines, their preparation and use